{
  "09e5f949-e170-4bd3-baac-77e377ed4821": {
    "objectives": {
      "primary": [
        {
          "ser_num": 1,
          "text": "To describe the PK parameters following a single SC administration of tezepelumab 70 mg in children with mild, moderate, or severe asthma"
        }
      ],
      "secondary": [
        {
          "ser_num": 1,
          "text": "To evaluate the immunogenicity of tezepelumab"
        }
      ],
      "safety": [
        {
          "ser_num": 1,
          "text": "To evaluate the safety and tolerability following a single SC administration of tezepelumab 70Â mg"
        }
      ],
      "exploratory": [
        {
          "ser_num": 1,
          "text": "To evaluate the PD following a single SC administration of tezepelumab 70 mg"
        }
      ]
    },
    "endpoints": {
      "primary": [
        {
          "ser_num": 1,
          "text": "Maximum concentration (C<sub>max</sub>) Time to C<sub>max</sub> (t<sub>max</sub>) Area under the concentration-time curve (AUC) Terminal phase elimination half-life (t 1\\/2 ) Apparent clearance (CL\\/F) Apparent steady-state volume of distribution (V<sub>ss</sub>\\/F)"
        }
      ],
      "derived_info": {
        "primary": {
          "derived_count": 6,
          "derived_mechanism": [
            "Maximum concentration (Cmax)",
            "Time to Cmax (tmax)",
            "Area under the concentration-time curve (AUC)",
            "Terminal phase elimination half-life (t1/2)",
            "Apparent clearance (CL/F)",
            "Apparent steady-state volume of distribution (Vss/F)"
          ]
        },
        "secondary": {
          "derived_count": 1,
          "derived_mechanism": ["Presence of anti-drug antibodies (ADA)"]
        },
        "safety": {
          "derived_count": 4,
          "derived_mechanism": [
            "Adverse events/serious adverse events",
            "Vital signs",
            "Laboratory parameters",
            "Electrocardiogram (ECG)"
          ]
        },
        "exploratory": {
          "derived_count": 4,
          "derived_mechanism": [
            "Pulmonary function (FEV1, FVC)",
            "Blood eosinophil levels",
            "FENO",
            "PQoL"
          ]
        }
      },
      "secondary": [
        {
          "ser_num": 1,
          "text": "Presence of anti-drug antibodies (ADA)"
        }
      ],
      "safety": [
        {
          "ser_num": 1,
          "text": "Adverse events\\/serious adverse events Vital signs Laboratory parameters Electrocardiogram (ECG)"
        }
      ],
      "exploratory": [
        {
          "ser_num": 1,
          "text": "Pulmonary function (FEV<sub>1</sub> FVC) Blood eosinophil levels FENO PQoL"
        }
      ]
    }
  }
}
